Info, dépêche ou communiqué de presse


société :

STEDIM

secteur : Equipement et fournitures médicales
vendredi 26 mars 2010 à 16h05

Sartorius Stedim Biotech : Document d''information annuel 2009 - 2010


Regulatory News:

Document Type Title of the Publication Website BALO AMF EURONEXT LA TRIBUNE Business Wire
2009
Press release: results First-Quarter 2009 Figures 2009 April 23 - - April 23 April 23 April 23
Results: 3-month report Sartorius Stedim Biotech Group: First-Quarter Report January to March 2009 April 29 - April 29 April 29 - April 29
Press release : liquidity contract Modification du contract de liquidit contract avec la Socit de Bourse Gilbert Dupont May 19 - May 19 May 19 - May 19
Release : publication Comptes annuels avec avis d'approbation des comptes et dcision d'affectation du rsultat (French only) - June 3 - - - -
Release Sartorius Stedim Biotech S.A. : Declaration Relative to the Number of Shares and Voting Rights Making up the Issued Capital June 5 - June 5 June 5 - June 5
Press release: SARTORIUS SARTORIUS: Rappel des principales caractristiques des droits garantie consentis en juillet 2007

June 26

-

June 26

June 26

-

June 26

Press release: SARTORIUS Reminder concerning the main characteristics of the guarantee rights from July 2007

June 27

- - - - -
Release : liquidity contract Bilan semestriel du contrat de Liquidit July 2 - July 2 July 2 - July 2
Release Sartorius Stedim Biotech S.A. : Declaration Relative to the Number of Shares and Voting Rights Making up the Issued Capital July 3 - July 3 July 3 - July 3
Release Sartorius Stedim Biotech: Modification du contrat de liquidite contracte avec la Socit de Bourse Gilbert Dupont (French only) July 22 - July 22 July 22 - 22 July
Press release: results Sartorius Stedim Biotech: Sales Revenue up 7%; EBITA Plus 35% July 28 - July 28 July 28 July 28 July 28
Release Maturit des droits garantie: Sartorius annonce que le montant d au titre des droits garantie sera e 20 euros par droit garantie (French only) - - - - July 30 -
Results: 6-month report Sartorius Stedim Biotech Group: First-Half Report January to March 2009 July 31 - July 31 July 31 - July 31
Release Sartorius Stedim Biotech: Document availability communications August 3 - August 3

August 3

- August 3
Release Sartorius Stedim Biotech S.A. : Declaration Relative to the Number of Shares and Voting Rights Making up the Issued Capital August 4 - August 4 August 4 - August 4
Press release: results

Sartorius Stedim Biotech: Nine-Month Figures for 2009: Sales Revenue up 8.6%; Underlying EBITA up 55.9%

October 22 - October 22 October 22 October 22 October 22
Results: 9-month report Sartorius Stedim Biotech Group: Nine-Month Report January to March 2009 October 29 - October 29 October 29 - October 29
Release Sartorius Stedim Biotech: Document availability communications October 29 - October 29 October 29 - October 29
Release

Sartorius Stedim Biotech S.A. : Declaration Relative to the Number of Shares and Voting Rights Making up the Issued Capital

December 3 - December 3 December 3 - December 3
2010
Release : liquidity contract Bilan annuel du contrat de Liquidit January 4 - January 4 January 4 - January 4
Release

Sartorius Stedim Biotech S.A. : Declaration Relative to the Number of Shares and Voting Rights Making up the Issued Capital

February 5 - February 5 February 5 - February 5
Press release: results

Highly satisfactory performance in 2009

February 10 - February 10 February 10 February 10 February 10
Press release Dividend Proposal by the Board

March 4

- March 4 March 4 - March 4
Release Sartorius Stedim Biotech S.A. : Declaration Relative to the Number of Shares and Voting Rights Making up the Issued Capital March 5 - March 5 March 5 - March 5
Reference Document 2009, french version Groupe Sartorius Stedim Biotech | Documentde Rfrence 2009 March 9 - March 9 March 9 - March 9
Convocation

Assembles d'actionnaires et de
porteurs de parts (French only)

March 12 March 10 - - - -

ContactsSartorius Stedim Biotech
Dominic Grone ; Communication du Groupe
Tl. : +49 (0)551/ 308-3324; Fax : +49 (0)551/ 308-3572 ;
Courriel :


Copyright Business Wire 2010
© 2002-2025 BOURSICA.COM, tous droits réservés.

Réalisez votre veille d’entreprise en suivant les annonces de la Bourse

Par la consultation de ce site, vous acceptez nos conditions (voir ici)

Page affichée jeudi 11 septembre 2025 à 11h37m34